Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi‐site pilot trial
Addiction · 2024
DOI: 10.1111/add.16364 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Addiction, 2024. Verfasst von Gerald Cochran und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Patient Navigation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCIPC CDC HHS, CDC HHS, Centers for Disease Control and Prevention.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background and aims Patient navigation (PN) may benefit pregnant individuals with opioid use disorder (OUD) by improving treatment adherence. We examined participant enrollment, session delivery and assessment feasibility for a PN intervention among pregnant participants and compared PN preliminary effectiveness for OUD treatment engagement with participants in usual care (UC).
Design
This study was a pilot single‐blinded multi‐site randomized trial.
Setting
Two academic medical centers in Pennsylvania ( n = 57) and Utah ( n = 45), United States participated.
Participants
One hundred and two pregnant adult participants unestablished (fewer than 6 weeks) on medication for OUD (MOUD) were randomized to PN ( n = 53) or UC ( n = 49).
Intervention
PN was composed of 10 prenatal sessions (delivered after baseline but before the prenatal assessments) and four postnatal sessions (delivered before the 2‐ and 6‐month postpartum assessments) focused upon OUD treatment and physical/mental health needs. UC involved brief case management.
Measurements
Feasibility assessments included consent, session delivery and assessment rates. Mixed‐effect models for intent‐to‐treat (ITT) and per protocol (PP, received six or more sessions) populations were estimated to compare outcomes of MOUD use, secondary outcomes of substance use disorder (SUD) treatment attendance and non‐prescribed opioid use, and exploratory outcome of overdose at baseline, predelivery and 2 and 6 months postpartum.
Findings
We consented 87% (106 of 122) of the proposed target, delivered ~60% of sessions delivered and completed ≥ 75% assessments. PN ITT and PP had better MOUD adherence, SUD treatment attendance, non‐prescribed opioid use and overdose outcomes than UC. Notable changes included good evidence for greater percentage change in days for PN PP MOUD use from baseline to 2 months postpartum [PN = 28.0 versus UC = −10.9, 95% confidence interval (CI) = 9.7, 62.1] and some evidence for baseline to 6 months postpartum (PN = 45.4 versus UC = 23.4, 95% CI = −0.7, 48.2). PN PP percentage change in days for SUD treatment attendance also showed good evidence for improvements from baseline to prenatal assessment (PN = 7.4 versus UC = −21.3, 95% CI = 3.3, 53.5). PN compared to UC participants reported fewer overdoses at 2 months (PN = 11.9%/UC = 16.1%) and at 6 months postpartum (PN = 3.8%/UC = 6.2%).
Conclusions
Patient navigation appears to be associated with improvements in opioid use disorder treatment engagement and overdoses during pregnancy. This pilot trial shows the feasibility of the intervention and a future large‐scale trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
- Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.
- Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Utah Health, Salt Lake City, UT, USA.
- Department of Obstetrics, Gynecology and Reproductive Sciences, UPMC, Pittsburgh, PA, USA.
- Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT, USA.
ORCID-Profile: Gerald Cochran, Elizabeth E Krans, Ralph Tarter
Förderung
- NCIPC CDC HHS
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Cochran, G., Smid, M. C., Krans, E. E., Yu, Z., Carlston, K., White, A., Abdulla, W., Baylis, J., Charron, E., Okifugi, A., Gordon, A. J., Lundahl, B., Silipigni, J., Seliski, N., Haaland, B., & Tarter, R. (2024). Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi‐site pilot trial. Addiction. https://doi.org/10.1111/add.16364
Vancouver
Cochran G, Smid MC, Krans EE, Yu Z, Carlston K, White A, et al. Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi‐site pilot trial. Addiction. 2024. doi:10.1111/add.16364
BibTeX
@article{Cochran2024,
author = {Cochran, Gerald and Smid, Marcela C and Krans, Elizabeth E and Yu, Ziji and Carlston, Kristi and White, Ashley and Abdulla, Walitta and Baylis, Jacob and Charron, Elizabeth and Okifugi, Akiko and Gordon, Adam J and Lundahl, Brad and Silipigni, John and Seliski, Natasha and Haaland, Benjamin and Tarter, Ralph},
title = {Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi‐site pilot trial},
journal = {Addiction},
year = {2024},
doi = {10.1111/add.16364}
}
EUVIMED